Respiratory Disease Clinical Trial
Official title:
Comparison of the Efficiency of Chest Physiotherapy Applied in a Different Order in Pediatric Intensive Care Patients
Verified date | November 2022 |
Source | Biruni University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study intends to compare the impact of chest physiotherapy applied with two different methods on physiologic parameters in children hospitalized in the intensive care unit. In the intensive care unit where the study was conducted, the patients who have a respiratory disorder and receive supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask are first administered an inhaler drug therapy placed in the physician's order. It is followed by chest physiotherapy and then oropharyngeal and nasopharyngeal aspiration. However, in practice rendered by the researcher, it is suggested that when chest physiotherapy and aspiration are administered in the first place and then followed by an inhaler drug therapy, it might have a more positive impact on the patient's physiologic parameters. For this reason, it is intended to compare the efficiency of chest physiotherapy applied in a different order.
Status | Completed |
Enrollment | 42 |
Est. completion date | November 30, 2022 |
Est. primary completion date | November 4, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Month to 6 Years |
Eligibility | Inclusion Criteria: - Hospitalized patients at Cerrahpasa Faculty of Medicine Pediatric Intensive Care Unit 1, - Aged between 1 months-6 years, - Having been in intensive care for at least two days, - Concious pediatric patient, - Receiving supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask, - Being administered chest physiotherapy (Tapotement or Vibration), - Being administered oropharyngeal and nasopharyngeal aspiration, - Inhaler drug therapy included in the patient's order, - Parents, volunteering for the study. Exclusion Criteria: - Parents not volunteering for the study, - Patients younger than 1-month or older than 6-years old, - Not receiving supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask - Not being administered oropharyngeal and nasopharyngeal aspiration, - Inhaler drug therapy is not included in the physician's order. |
Country | Name | City | State |
---|---|---|---|
Turkey | Selmin Köse | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Selmin Kose |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Physiological Parameter Assessment Form Showing The Change In Respiration rate/min | Chest physiotherapy applied in a different order in pediatric intensive care patients causes a difference in the patient's physiologic parameters.This form prepared by the researcher includes recording respiration rate/min in the clinic. The researcher will be assessed the respiration rate/min at least four times before and after the chest physiotherapy in a day. The "Patient Physiologic Parameter Assessment Form" information will be recorded before the application and 30 minutes after the application. It is known that the stress hormones epinephrine and norepinephrine half-life is 1-3 minutes, and it is believed that after a stressful invasive intervention, the release of stress hormones increases but turns back to their normal levels in 15-20 minutes. Based on this information, the respiration rate/min will be recorded in the "Patient Physiologic Parameter Assessment Form" after 30 minutes. | This procedure will be applied to each patient for 30 minutes 4 times a day. It will be applied for at least 2 days and until the patient is discharged. | |
Other | Physiological Parameter Assessment Form Showing The Change In Blood pressure (mmHg) | Chest physiotherapy applied in a different order in pediatric intensive care patients causes a difference in the patient's physiologic parameters.This form prepared by the researcher includes recording respiration blood pressure (mmHg) in the clinic. The researcher will be assessed the blood pressure (mmHg) at least four times before and after the chest physiotherapy in a day. The "Patient Physiologic Parameter Assessment Form" information will be recorded before the application and 30 minutes after the application. It is known that the stress hormones epinephrine and norepinephrine half-life is 1-3 minutes, and it is believed that after a stressful invasive intervention, the release of stress hormones increases but turns back to their normal levels in 15-20 minutes. Based on this information, the blood pressure (mmHg) will be recorded in the "Patient Physiologic Parameter Assessment Form" after 30 minutes. | This procedure will be applied to each patient for 30 minutes 4 times a day. It will be applied for at least 2 days and until the patient is discharged. | |
Other | Physiologic Parameter Assessment Form Showing The Change In Blood gas (mmHg) | In the clinic, although the time varies depending on the physician's request, the blood gas will driven twice a day routinely. | The blood gas will driven twice a day routinely. | |
Primary | Physiological Parameter Assessment Form Showing The Change In Heart Rate | Chest physiotherapy applied in a different order in pediatric intensive care patients causes a difference in the patient's physiologic parameters.This form prepared by the researcher includes recording pulse rate/min in the clinic. The researcher will be assessed the pulse/min at least four times before and after the chest physiotherapy in a day. The "Patient Physiologic Parameter Assessment Form" information will be recorded before the application and 20 minutes after the application. It is known that the stress hormones epinephrine and norepinephrine half-life is 1-3 minutes, and it is believed that after a stressful invasive intervention, the release of stress hormones increases but turns back to their normal levels in 15-20 minutes. Based on this information, the pulse will be recorded in the "Patient Physiologic Parameter Assessment Form" after 20 minutes. | This procedure will be applied to each patient for 30 minutes 4 times a day. It will be applied for at least 2 days and until the patient is discharged. | |
Secondary | Physiological Parameter Assessment Form Showing The Change In SPO2% | Chest physiotherapy applied in a different order in pediatric intensive care patients causes a difference in the patient's physiologic parameters.This form prepared by the researcher includes recording SPO2% in the clinic. The researcher will be assessed the SPO2% at least four times before and after the chest physiotherapy in a day. The "Patient Physiologic Parameter Assessment Form" information will be recorded before the application and 30 minutes after the application. It is known that the stress hormones epinephrine and norepinephrine half-life is 1-3 minutes, and it is believed that after a stressful invasive intervention, the release of stress hormones increases but turns back to their normal levels in 15-20 minutes. Based on this information, the SPO2% will be recorded in the "Patient Physiologic Parameter Assessment Form" after 30 minutes. | This procedure will be applied to each patient for 30 minutes 4 times a day. It will be applied for at least 2 days and until the patient is discharged. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03376204 -
Pain Mechanisms in Patients With Bronchiectasis
|
||
Not yet recruiting |
NCT05902702 -
Isotonic Saline for Children With Bronchiolitis
|
N/A | |
Recruiting |
NCT05246098 -
REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI
|
||
Completed |
NCT04467190 -
Investigation of Inflammacheck to Measure Exhaled Breath Condensate Hydrogen Peroxide in Respiratory Conditions
|
||
Not yet recruiting |
NCT05374148 -
Respiratory Health Problems Among Workers in Ferrosilicon Alloys Industry in Aswan-Eygpt.
|
||
Recruiting |
NCT04502368 -
Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients
|
||
Recruiting |
NCT05775952 -
Airway Remodeling and Rhinovirus in Asthmatics
|
||
Active, not recruiting |
NCT02681848 -
What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
|
||
Recruiting |
NCT06002685 -
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
|
N/A | |
Enrolling by invitation |
NCT03319446 -
Collection of Anonymized Samples
|
N/A | |
Recruiting |
NCT04287959 -
SWISH Trial (Strategies for Weaning Infants on Supportive High Flow)
|
N/A | |
Completed |
NCT05017727 -
Closed-loop Oxygen Control in Ventilated Infants Born at or Near Term
|
||
Completed |
NCT04607330 -
Protein Top-up Acceptability Study for Patients With Increased Protein Needs
|
N/A | |
Completed |
NCT03334916 -
A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
|
Phase 4 | |
Completed |
NCT04649736 -
Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients
|
N/A | |
Completed |
NCT03661801 -
Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
|
||
Enrolling by invitation |
NCT03322254 -
How Respiratory Pathogens Panel Results Affect Patients' Plan of Care
|
||
Recruiting |
NCT03937583 -
Screening for Cancer in Patients With Unprovoked VTE
|
Phase 4 | |
Not yet recruiting |
NCT06026163 -
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
|
Phase 2/Phase 3 | |
Completed |
NCT04581096 -
Mapping COVID-19 Spread in a Tertiary Hospital
|